Development of Olaparib for BRCA-Deficient Recurrent Epithelial Ovarian Cancer

Overview of attention for article published in Clinical Cancer Research, August 2015

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 6 X users

Readers on

mendeley: 90 Mendeley

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 18,795 followers.

RT @gedefo_sefh: "Olaparib for the Treatment of Ovarian Cancer" http://t.co/rBbm1LI7eH

"Olaparib for the Treatment of Ovarian Cancer" http://t.co/rBbm1LI7eH

Olaparib for the Treatment of Ovarian Cancer http://t.co/fFDvSeY14V

Development of Olaparib for BRCA-Deficient Recurrent Epithelial Ovarian Cancer. http://t.co/0GBAAXDSdF

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 2 additional X posts.